Principal Securities’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Buy |
1,715
+333
| +24% | +$41.9K | ﹤0.01% | 1206 |
|
|
2025
Q1 | $189K | Hold |
1,382
| – | – | ﹤0.01% | 1156 |
|
|
2024
Q4 | $189K | Buy |
1,382
+270
| +24% | +$36.9K | ﹤0.01% | 1156 |
|
|
2024
Q3 | $128K | Buy |
1,112
+219
| +25% | +$25.2K | ﹤0.01% | 1288 |
|
|
2024
Q2 | $123K | Buy |
893
+170
| +24% | +$23.4K | ﹤0.01% | 1236 |
|
|
2024
Q1 | $99.7K | Buy |
723
+151
| +26% | +$20.8K | ﹤0.01% | 1278 |
|
|
2023
Q4 | $75.4K | Buy |
+572
| New | +$75.4K | ﹤0.01% | 1302 |
|